Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials
The Lancet Infectious Diseases（2022）
摘要
National Health and Medical Research Council (NHMRC).
更多查看译文
关键词
pneumococcal conjugate vaccines,otitis media,nasopharyngeal carriage,immunogenicity,ten-valent
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要